AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,134,000 | -44.5% | 405,178 | -50.2% | 0.00% | -100.0% |
| Q3 2020 | $2,044,000 | -84.5% | 814,284 | -16.1% | 0.00% | -75.0% |
| Q2 2020 | $13,173,000 | +88.9% | 970,031 | +5.4% | 0.00% | +100.0% |
| Q1 2020 | $6,974,000 | +19.9% | 920,031 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,815,000 | +61.3% | 920,031 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $3,606,000 | -19.0% | 920,031 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $4,452,000 | -49.7% | 920,031 | -14.9% | 0.00% | -66.7% |
| Q1 2019 | $8,854,000 | +153.2% | 1,081,061 | +70.9% | 0.00% | +200.0% |
| Q4 2018 | $3,497,000 | +77.2% | 632,459 | +205.3% | 0.00% | 0.0% |
| Q1 2018 | $1,974,000 | -70.9% | 207,173 | -54.6% | 0.00% | -50.0% |
| Q4 2017 | $6,789,000 | -30.5% | 456,573 | -8.0% | 0.00% | -50.0% |
| Q3 2017 | $9,764,000 | +579.5% | 496,406 | +396.4% | 0.00% | +300.0% |
| Q2 2017 | $1,437,000 | +72.3% | 100,000 | +233.3% | 0.00% | – |
| Q2 2014 | $834,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |